---

Market Overview

---

The global market for anti-snoring devices is projected to reach USD 1.81 billion by 2027, up from USD 1.14 billion in 2021, with a compound annual growth rate (CAGR) of 7.98% from 2022 to 2027. This growth can be attributed to several key factors. First, there is a high prevalence of snoring and obstructive sleep apnea (OSA), leading to a greater demand for anti-snoring devices. Second, there is increasing awareness of the adverse effects of snoring on health, which is driving individuals to seek solutions. Third, technological advancements in anti-snoring devices are improving their effectiveness and comfort. Lastly, the aging population is contributing to the growth of this market.

Snoring occurs when the throat and tongue tissues become overly relaxed, causing air to vibrate the tissue as it passes through, resulting in the sound of snoring. To address this issue, technological advancements have positively impacted the anti-snoring market. Smart anti-snoring devices are now available, which incorporate daily device functionalities and enhanced performance. These devices can be interconnected with other smart devices in the home, thanks to IoT connectivity options. This expanded functionality has further increased the appeal of these devices.

During the forecast period, the oral anti-snoring devices market is expected to experience faster growth compared to CPAP and other devices. This can be attributed to higher patient adherence, as oral devices are readily available at dentists and online channels, making them more accessible for manufacturers to market their products.

Traditional solutions in the anti-snoring devices market, such as mouthguards, strips, and bands, are often uncomfortable for users. In response, medical technology start-ups are developing non-invasive anti-snoring devices. These devices detect the sound of snoring and gently move the snorer’s head to restore normal breathing and stop snoring.

One notable company in this field is Smart Nora, a Canadian company that offers non-invasive anti-snoring solutions. Their product consists of a Pebble device that detects snoring, a padded pillowcase, and a quiet pump that inflates and contracts the padded insert. When snoring is detected, the pillow is moved, stimulating the neck muscles to restore natural breathing and improve sleep quality.

Another company, Signifier Medical Technologies, offers innovative devices such as eXciteOSA. eXciteOSA is a removable tongue muscle stimulation device that provides nerve muscle stimulation to reduce snoring and mild sleep apnea in patients over 18 years old.

Treating sleep apnea is crucial, as it can improve symptoms, lower blood pressure, enhance glucose control, and reduce the risk of movement disorders. Early treatment is particularly important due to the potential irreversibility of the consequences associated with the disease.

Several companies have recently introduced new and innovative anti-snoring devices to the market. For example, Illusion Aligners launched the Illusion Aligner oral anti-snoring device, which is easy to wear, effective, and comfortable. The FDA has granted marketing approval for eXcite OSA devices developed by Signifier Medical Technologies. GoodSmonia also plans to launch a Smart stop-snoring device that increases blood flow and stimulates muscle tone in the soft palate, making them tighter and stronger.

Continuous Positive Airway Pressure (CPAP) devices have evolved significantly since their introduction in 1981. Modern CPAP machines are lighter, quieter, and more efficient compared to older models. An innovative feature is the Automatic Airway Pressure Device (AutoPAP), which adjusts airway pressure to meet the patient’s needs automatically.

State-of-the-art CPAP and AutoPAP machines include microprocessors that store high-density data, conduct self-tests, and provide detailed reports on patient compliance and usage. These machines offer accurate daily usage measurements, tracking mask-on-time instead of overall on-time. Additionally, modern CPAP machines are designed to operate with reduced noise levels, improving the sleeping experience for patients and their bed partners.

In conclusion, the global anti-snoring devices market is experiencing significant growth, driven by factors such as the high prevalence of snoring and OSA, increasing awareness of health risks associated with snoring, technological advancements, and an aging population. Innovative non-invasive devices and improved CPAP technologies are emerging to provide more effective and comfortable solutions for individuals seeking relief from snoring and sleep apnea.

---

Market Segmentation

---

The market is segmented based on various factors, including product, age group, gender, end user, and geography.

Segmentation by Product
Oral Devices
Pap Devices
Nasal Devices
Others

Segmentation by Application
Body Contouring & Cellulite Reduction
Skin Tightening & Skin Lighteners
Facial Aesthetic
Breast Augmentation
Others

Segmentation by Age Group
Between 40 & 59 Years
60 & Above Years
Below 40 Years

Segmentation by Gender
Men
Women

Segmentation by End User
Sleep Labs & Dental Clinics
Home Healthcare
Hospitals

Segmentation by Geography
North America – US, Canada
Europe – Germany, France, UK, Italy, Spain
APAC – China, Japan, India, South Korea, Australia
Latin America – Brazil, Mexico, Argentina
Middle East & Africa – South Africa, Saudi Arabia, Turkey

The global market for oral anti-snoring devices recorded a significant share of approximately 46.33% in 2021. This segment is expected to be higher due to the effectiveness of oral appliances in keeping air passages open by adjusting the position of the jaw, tongue, and soft palate. Patients using oral instruments should consult a dentist to ensure proper fitting and placement.

Oral appliance therapy (OAT) encompasses various styles and technologies, including Mandibular Advancement Devices (MADs), tongue retaining devices, Herbst-style oral appliances, and smart OAT. MADs, which are commonly used to treat sleep apnea, function by moving the jaw forward. Thermoplastic MADs can be created and adjusted by patients at home.

OAT is experiencing rapid growth with a compound annual growth rate (CAGR) of 8.44%. It is particularly preferred by patients who have low compliance with Continuous Positive Airway Pressure (CPAP) devices. As noncompliance with CPAP devices increases, oral OSA devices such as mandibular advancement devices, tongue retaining devices, and implants are recommended. Therefore, OAT is showing emerging growth in the anti-snoring devices market.

In 2021, the 40-59 age group accounted for a significant share of approximately 54.68% in the global anti-snoring devices market. This segment is expected to be higher because the working adult population in this age range faces daily challenges from work to home. Risk factors such as work-related stress, alcohol consumption, chronic smoking, and obesity contribute to the development of OSA and snoring symptoms in this age group.

According to the Mind the Workplace report released by Mental Health America (MHA) in 2022, more than 11,300 U.S. employees across 17 industries reported increasing difficulty in concentrating at work. The shift towards a 24/7 society, driven by urbanization and the use of technology, has disrupted people’s sleep cycles. This has led to increased stress on the brain and sleeping problems, especially among the working population.

The male segment dominates the global anti-snoring devices market with a significant share of approximately 62.01%. This can be attributed to the association between obesity and serious health risks. Severe obesity in men further increases the risk of complications such as coronary artery disease and end-stage renal disease. Obesity prevalence is highest among middle-aged men, and the prevalence of snoring and obstructive sleep apnea is also high in this group.

Sleep labs and dental clinics reported a significant share of approximately 43.07% in the global anti-snoring devices market in 2021. Different diagnostic methods, including in-lab testing and home sleep testing, are available based on patient convenience and disease condition. In-lab testing often involves polysomnography (PSG), considered the gold standard diagnostic test.

Dentists play an important role in preventing snoring through oral therapy with splints. Customized splints, similar to sports mouthguards, can be fabricated by dentists. Mandibular Advancement Devices (MADs) slowly move the jaw forward to a more favorable position, preventing airway blockage by soft tissues.

North America accounted for a significant share of approximately 33.31% in the global anti-snoring devices market. The region’s market growth is driven by factors such as high prevalence of sleep disorders, changing lifestyles, and the presence of various vendors. The U.S., in particular, is a major revenue generator due to lifestyle changes and sedentary habits.

Asia Pacific (APAC) holds a 22.56% share in the global anti-snoring devices market and is projected to reach USD 443.9 million by 2027. The region’s aging population and mental health issues related to work stress and the impact of the pandemic contribute to an increased incidence of sleep disorders. Manufacturing capabilities in countries like China, Japan, and India also drive the market growth in this region. Japan, in particular, has a high prevalence of mental health issues and work-related stress.

---

Competitive Landscape

---

The global market for anti-snoring devices demonstrates a high level of diversity, housing numerous global and local players that offer a wide range of anti-snoring devices, including oral devices, PAP devices, nasal devices, and other variants. These players contribute to the consolidation of the market, with global companies holding significant shares. Prominent industry leaders such as Philips, ResMed, Fisher & Paykel, Apnea Sciences, and Tomed dominate the market and possess substantial market shares.

To maintain their competitiveness, global players prioritize the development of innovative products and the expansion of their product portfolios. They allocate significant investments towards research and development and engage in extensive product development activities to enhance their offerings. Manufacturers like ResMed, Koninklijke Philips N.V, SomnoMed, and ProSomnus consistently focus on product advancement, introducing sophisticated anti-snoring devices embedded with new technologies, all aiming to augment their presence within the market.

Key companies profiled in this report include Apnea Science, ResMed, Koninklijke Philips N.V, Fisher & Paykel, Tomed, Illusion Aligners, Sleep Number, VVFLY Electronics, Signifier Medical Technologies, Glidewell, Smart Nora, ProSomnus, SomnoMed, REM-Fit, Downtown Denver Sleep Solutions, MEDITAS, ApneaMed, Wolfson Holdco, Rhinomed, DeVilbiss Healthcare, White Dental Healthcare, Hupnos, Nitetronic, Nyxoah, Oventus, Vivos Therapeutics, Somnowell, ZQuiet, RemSleep Holdings, Humetron, Nidra Care.

---

Recent Industry Developments

---

Illusion Aligners, in May 2022, introduced a cutting-edge anti-snoring device renowned as the Illusion Aligner. This oral device is acclaimed for its ease of use, effectiveness, and comfort, enabling users to achieve uninterrupted and restful sleep each night.

In February 2021, Signifier Medical Technologies launched an innovative anti-snoring device called eXciteOSA. This groundbreaking device utilizes electrical muscle stimulation through a tongue-based mouthpiece. Equipped with four electrodes, two positioned above the tongue and two below, eXciteOSA has received approval from the U.S. Food and Drug Administration (FDA) for prescription-only commercialization.

---

Key Questions Answered

---

What is the market size of the global anti-snoring devices industry?

The global anti-snoring devices market was valued at USD 1.14 billion in 2021 and is projected to reach USD 1.81 billion by 2027.

What is the growth rate of the global anti-snoring devices market?

The global anti-snoring devices market is anticipated to grow at a compound annual growth rate (CAGR) of 7.98% from 2022 to 2027.

What are the factors driving the growth of the global anti-snoring devices market?

Some key trends contributing to the growth of the global anti-snoring devices market include the introduction of smart anti-snoring devices, the entry of sleep-focused startups into the market, the development of advanced Herbst-style oral appliances, and the launch and approval of new anti-snoring devices.

Who are the major players in the global anti-snoring devices market?

The leading companies in the global anti-snoring devices market are Apnea Science, ResMed, Koninklijke Philips N.V, Fisher & Paykel, and Tomed.

Which regions are expected to dominate the global anti-snoring devices market from 2021 to 2027?

North America is projected to dominate the global anti-snoring devices market during the forecast period. This dominance is attributed to various factors such as a high prevalence of sleep disorders, disrupted sleep patterns, and changing lifestyles in the region.